SCHEDULE OF EFFECTIVE INCOME TAX (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Jul. 31, 2026 |
Jul. 31, 2025 |
|
| Income Tax Disclosure [Abstract] | ||
| Net loss before recovery of income taxes | $ (35,325,292) | $ (26,556,140) |
| Expected income tax (recovery) expense | (9,537,829) | (7,170,160) |
| Tax rate changes and effect of taxes of subsidiaries at foreign rates | 1,785,571 | 1,448,710 |
| Share-based compensation and other non-deductible expenses | 531,294 | 240,070 |
| Share issuance costs booked directly to equity | (573,777) | (375,750) |
| Adjustments in respect of prior periods | 81,843 | 868,490 |
| R&D credits | (2,227,411) | (1,284,010) |
| Valuation allowance | 9,940,309 | 6,272,650 |
| Income tax (recovery) | ||
| X | ||||||||||
- Definition Income taxreconciliation reconciliationnondeductible nondeductibleexpense expenseadjustments adjustments adjustmentsin inrespect respectof ofprior priorperiods. No definition available.
|
| X | ||||||||||
- Definition IncomeTax taxreconciliation reconciliationnondeductible nondeductibleexpense expenseresearch researchand anddevelopment developmentcredits. No definition available.
|
| X | ||||||||||
- Definition IncomeTax taxreconciliation reconciliationnondeductible nondeductibleexpense expenseshare shareissuance issuancecost costbooked bookeddirectly directlyto toequity. No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|